FMP
co.don AG
CNWK.DE
XETRA
Inactive Equity
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
2.48 EUR
1.24 (50%)
About
ceo
Dipl.-Kfm. Dirk Hessel
sector
Healthcare
industry
Biotechnology
website
http://www.codon.de
exchange
XETRA
Description
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
CIK
N/A
ISIN
DE000A1K0227
CUSIP
D15352186
Address
Warthestrasse 21
Phone
49332843460
Country
DE
Employee
120
IPO Date
Feb 1, 2001
Summary
CIK
-
Exchange
XETRA
Industry
Biotechnology
Sector
Healthcare
CUSIP
D15352186
ISIN
DE000A1K0227
Country
DE
Price
2.48
Beta
1.91
Volume Avg.
9.39k
Market Cap
0
Shares
-
52-Week
1.195-1.275
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.82
P/B
-
Website
http://www.codon.de
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CNWK.DE News
It looks like there's no news available.
